Table 1. CYP2C9 and CYP2C19 genotyping: primer selection.

	Primer	Sequence*
CYP2C9
Exon 3	3S	5′-GGAGGATGGAAAACAGAGAC-3′ (337–356)
	3AS	5′-GATATGGCCACCCCTGA-3′ (703–687)
	31S	5′-AGGAGCATTGAGGACC-3′§-3′ (548–563)
	31AS	5′-GCTTCCTCTTGAACACA-3′§-3′ (579–563)
Exon 7	7S	5′-CTCCTTTTCCATGAGTTTTTACT-3′ (34–56)
	7AS	5′-GATACTATGAATTTGGGACTTC-3′ (317–296)
CYP2C19
Exon 5	5SR†	5′-CAGAGCTTGGCATATTGTATC-3′(8–28)
	5AS†	5′-GTAAACACACAACTAGTCAATG-3′ (328–307)
	5ISc	5′-ATCATTGATTATTTCCCA §-3′ (100–117)
	5IAS‡	5′-AATTTGTTATGGGTTCCC §-3′ (134–117)
Exon 4	4Sc	5′-TATGAAGTGTTTTATATCTAATGTTTACTCA-3′(21–51)
	4AS‡	5′-ACTTCAGGGCTTGGTCAATATAGA-3′(329–306)
	4IS‡	5′-GTAAGGACCCCCTGA §-3′ (220–234)
	4IAS‡	5′-GGCCTTACCTGGATC §-3′ (248–234)

^*Nucleotide positions according to GenBank Accession no. L32982 (exon 4), L31506 (exon 5), L16878 (exon 3) and L16881 (exon 7).

^†From Xiao et al.[22].

^‡From Hersberger et al.[10].

^§Nucleotides that correspond to the target point mutation.